diabetes : Sanofi and MannKind Announce Global ...

Search for the latest updates on diabetes

News

Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin GlobeNewswire via Yahoo! Finance  - 58 minutes
PARIS and VALENCIA, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Sanofi (EURONEXT: SAN and NYSE: SNY) and MannKind Corporation (MNKD) announced ...

Sanofi, MannKind in Global Pact for Inhaled Insulin Nasdaq  - 3 minutes
Sanofi, MannKind in Global Pact for Inhaled Insulin

Sanofi to Pay MannKind Up to $925m for Inhaled Insulin Bloomberg  - 53 minutes
Sanofi (SAN) agreed to pay MannKind Corp. (MNKD) as much as $925 million for rights to the world's only available inhaled insulin less than ...

Sanofi, MannKind agree licensing deal for Afrezza insulin Reuters via Yahoo! Finance  - 56 minutes
PARIS, Aug 11 (Reuters) - French drugmaker Sanofi and MannKind Corp have agreed a worldwide licensing deal to develop and market inhaled ...

Current diabetes news »

Search for the latest updates on diabetes

Manage alerts  ·   Unsubscribe  ·   Privacy Policy

 

Tip: To search for an exact phrase, put quotation marks around two or more words.

 

You received this email because you subscribed to Yahoo! Alerts.